NCT05223101View on ClinicalTrials.gov

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Hypertension
Interventions
DRUG

Telminone 80 mg

Single administration of telmisartan 80 mg

DRUG

Drug: Micardis 80 mg

Single administration of telmisartan 80 mg

Trial Locations (1)

28644

RECRUITING

Chungbuk National University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY